---
layout: default
title: A Multicenter Benchmark of Multiple Instance Learning Models for Lymphoma Subtyping from HE-stained Whole Slide Images
---

# A Multicenter Benchmark of Multiple Instance Learning Models for Lymphoma Subtyping from HE-stained Whole Slide Images

**arXiv**: [2512.14640v1](https://arxiv.org/abs/2512.14640) | [PDF](https://arxiv.org/pdf/2512.14640.pdf)

**ä½œè€…**: Rao Muhammad Umer, Daniel Sens, Jonathan Noll, Christian Matek, Lukas Wolfseher, Rainer Spang, Ralf Huss, Johannes Raffler, Sarah Reinke, Wolfram Klapper, Katja Steiger, Kristina Schwamborn, Carsten Marr

**åˆ†ç±»**: cs.CV, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

**å¤‡æ³¨**: 17 pages

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºæ·‹å·´ç˜¤äºšåž‹å¤šä¸­å¿ƒåŸºå‡†æ•°æ®é›†ï¼Œè¯„ä¼°å¤šç¤ºä¾‹å­¦ä¹ æ¨¡åž‹åœ¨HEæŸ“è‰²åˆ‡ç‰‡å›¾åƒä¸Šçš„æ€§èƒ½ã€‚**

ðŸŽ¯ **åŒ¹é…é¢†åŸŸ**: **äººå½¢/åŒè¶³æœºå™¨äºº (Humanoid & Biped)** **å…·èº«æ™ºèƒ½ä¸Žè¡¨å¾å­¦ä¹  (Embodied AI & Representation)**

**å…³é”®è¯**: `æ·‹å·´ç˜¤äºšåž‹` `å¤šç¤ºä¾‹å­¦ä¹ ` `ç—…ç†å›¾åƒ` `æ·±åº¦å­¦ä¹ ` `å¤šä¸­å¿ƒæ•°æ®` `åŸºå‡†æ•°æ®é›†` `HEæŸ“è‰²` `æ³›åŒ–èƒ½åŠ›`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. çŽ°æœ‰æ·‹å·´ç˜¤è¯Šæ–­æµç¨‹è€—æ—¶è€—åŠ›ï¼Œä¾èµ–æ˜‚è´µè®¾å¤‡å’Œä¸“ä¸šäººå‘˜ï¼Œæ·±åº¦å­¦ä¹ æœ‰æœ›ä»ŽHEæŸ“è‰²åˆ‡ç‰‡ä¸­æå–ä¿¡æ¯è¾…åŠ©è¯Šæ–­ã€‚
2. è®ºæ–‡æž„å»ºäº†é¦–ä¸ªå¤šä¸­å¿ƒæ·‹å·´ç˜¤åŸºå‡†æ•°æ®é›†ï¼Œå¹¶ç³»ç»Ÿè¯„ä¼°äº†å¤šç§ç—…ç†å­¦åŸºç¡€æ¨¡åž‹å’Œå¤šç¤ºä¾‹å­¦ä¹ èšåˆæ–¹æ³•ã€‚
3. å®žéªŒè¡¨æ˜Žæ¨¡åž‹åœ¨åŒåˆ†å¸ƒæ•°æ®ä¸Šè¡¨çŽ°è‰¯å¥½ï¼Œä½†åœ¨å¼‚åˆ†å¸ƒæ•°æ®ä¸Šæ³›åŒ–èƒ½åŠ›ä¸è¶³ï¼Œæœªæ¥éœ€æ›´å¤§è§„æ¨¡å¤šä¸­å¿ƒç ”ç©¶ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æ·‹å·´ç˜¤çš„åŠæ—¶å‡†ç¡®è¯Šæ–­å¯¹æŒ‡å¯¼ç™Œç—‡æ²»ç–—è‡³å…³é‡è¦ã€‚æ ‡å‡†çš„è¯Šæ–­æµç¨‹ç»“åˆäº†è‹æœ¨ç²¾-ä¼Šçº¢ï¼ˆHEï¼‰æŸ“è‰²çš„å…¨åˆ‡ç‰‡å›¾åƒä¸Žå…ç–«ç»„ç»‡åŒ–å­¦ã€æµå¼ç»†èƒžæœ¯å’Œåˆ†å­é—ä¼ å­¦æ£€æµ‹æ¥ç¡®å®šæ·‹å·´ç˜¤äºšåž‹ï¼Œè¿™ä¸ªè¿‡ç¨‹éœ€è¦æ˜‚è´µçš„è®¾å¤‡ã€ç†Ÿç»ƒçš„äººå‘˜ï¼Œå¹¶å¯¼è‡´æ²»ç–—å»¶è¯¯ã€‚æ·±åº¦å­¦ä¹ æ–¹æ³•å¯ä»¥é€šè¿‡ä»Žå¸¸è§„å¯ç”¨çš„HEæŸ“è‰²åˆ‡ç‰‡ä¸­æå–è¯Šæ–­ä¿¡æ¯æ¥è¾…åŠ©ç—…ç†å­¦å®¶ï¼Œä½†ç›®å‰ç¼ºä¹é’ˆå¯¹å¤šä¸­å¿ƒæ•°æ®ä¸Šæ·‹å·´ç˜¤äºšåž‹çš„å…¨é¢åŸºå‡†ã€‚æœ¬æ–‡æå‡ºäº†ç¬¬ä¸€ä¸ªå¤šä¸­å¿ƒæ·‹å·´ç˜¤åŸºå‡†æ•°æ®é›†ï¼Œæ¶µç›–å››ç§å¸¸è§çš„æ·‹å·´ç˜¤äºšåž‹å’Œå¥åº·å¯¹ç…§ç»„ç»‡ã€‚æˆ‘ä»¬ç³»ç»Ÿåœ°è¯„ä¼°äº†äº”ä¸ªå…¬å¼€å¯ç”¨çš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹ï¼ˆH-optimus-1ã€H0-miniã€Virchow2ã€UNI2ã€Titanï¼‰ä¸ŽåŸºäºŽæ³¨æ„åŠ›çš„ï¼ˆAB-MILï¼‰å’ŒåŸºäºŽTransformerçš„ï¼ˆTransMILï¼‰å¤šç¤ºä¾‹å­¦ä¹ èšåˆå™¨åœ¨ä¸‰ç§æ”¾å¤§å€æ•°ï¼ˆ10xã€20xã€40xï¼‰ä¸‹çš„æ€§èƒ½ã€‚åœ¨åŒåˆ†å¸ƒæµ‹è¯•é›†ä¸Šï¼Œæ¨¡åž‹åœ¨æ‰€æœ‰æ”¾å¤§å€æ•°ä¸‹å‡å®žçŽ°äº†è¶…è¿‡80%çš„å¤šç±»å¹³è¡¡å‡†ç¡®çŽ‡ï¼Œæ‰€æœ‰åŸºç¡€æ¨¡åž‹çš„æ€§èƒ½ç›¸ä¼¼ï¼Œä¸¤ç§èšåˆæ–¹æ³•ä¹Ÿè¡¨çŽ°å‡ºç›¸å½“çš„ç»“æžœã€‚æ”¾å¤§å€æ•°ç ”ç©¶è¡¨æ˜Žï¼Œ40xåˆ†è¾¨çŽ‡å·²è¶³å¤Ÿï¼Œæ›´é«˜çš„åˆ†è¾¨çŽ‡æˆ–è·¨æ”¾å¤§å€æ•°èšåˆæ²¡æœ‰å¸¦æ¥æ€§èƒ½æå‡ã€‚ç„¶è€Œï¼Œåœ¨å¼‚åˆ†å¸ƒæµ‹è¯•é›†ä¸Šï¼Œæ€§èƒ½å¤§å¹…ä¸‹é™è‡³60%å·¦å³ï¼Œçªå‡ºäº†æ˜¾è‘—çš„æ³›åŒ–æŒ‘æˆ˜ã€‚ä¸ºäº†æŽ¨åŠ¨è¯¥é¢†åŸŸçš„å‘å±•ï¼Œéœ€è¦æ¶µç›–æ›´å¤šç½•è§æ·‹å·´ç˜¤äºšåž‹çš„æ›´å¤§è§„æ¨¡çš„å¤šä¸­å¿ƒç ”ç©¶ã€‚æˆ‘ä»¬æä¾›äº†ä¸€ä¸ªè‡ªåŠ¨åŒ–çš„åŸºå‡†æµ‹è¯•æµç¨‹ï¼Œä»¥ä¿ƒè¿›æœªæ¥çš„ç ”ç©¶ã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³æ·‹å·´ç˜¤äºšåž‹è¯Šæ–­ä¸­ï¼Œä¾èµ–ä¼ ç»Ÿæ–¹æ³•è€—æ—¶è€—åŠ›çš„é—®é¢˜ï¼Œå¹¶æŽ¢ç´¢æ·±åº¦å­¦ä¹ åœ¨HEæŸ“è‰²åˆ‡ç‰‡å›¾åƒä¸Šçš„åº”ç”¨æ½œåŠ›ã€‚çŽ°æœ‰æ–¹æ³•ç¼ºä¹ç»Ÿä¸€çš„åŸºå‡†æ•°æ®é›†ï¼Œéš¾ä»¥è¯„ä¼°å’Œæ¯”è¾ƒä¸åŒæ¨¡åž‹çš„æ€§èƒ½ï¼Œå°¤å…¶æ˜¯åœ¨å¤šä¸­å¿ƒæ•°æ®ä¸Šçš„æ³›åŒ–èƒ½åŠ›ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯æž„å»ºä¸€ä¸ªå¤šä¸­å¿ƒã€å¤šäºšåž‹çš„æ·‹å·´ç˜¤æ•°æ®é›†ï¼Œå¹¶åœ¨æ­¤æ•°æ®é›†ä¸Šç³»ç»Ÿåœ°è¯„ä¼°å¤šç§çŽ°æœ‰çš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹å’Œå¤šç¤ºä¾‹å­¦ä¹ ï¼ˆMILï¼‰èšåˆæ–¹æ³•ã€‚é€šè¿‡ç»Ÿä¸€çš„åŸºå‡†ï¼Œå¯ä»¥æ›´å®¢è§‚åœ°æ¯”è¾ƒä¸åŒæ¨¡åž‹çš„æ€§èƒ½ï¼Œå¹¶å‘çŽ°æ¨¡åž‹åœ¨æ³›åŒ–èƒ½åŠ›æ–¹é¢çš„ä¸è¶³ã€‚

**æŠ€æœ¯æ¡†æž¶**ï¼šæ•´ä½“æ¡†æž¶åŒ…å«æ•°æ®å‡†å¤‡ã€ç‰¹å¾æå–å’Œåˆ†ç±»ä¸‰ä¸ªä¸»è¦é˜¶æ®µã€‚é¦–å…ˆï¼Œä»Žå¤šä¸ªä¸­å¿ƒæ”¶é›†HEæŸ“è‰²å…¨åˆ‡ç‰‡å›¾åƒï¼Œå¹¶è¿›è¡Œæ ‡æ³¨ã€‚ç„¶åŽï¼Œä½¿ç”¨é¢„è®­ç»ƒçš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹ï¼ˆå¦‚H-optimus-1, H0-mini, Virchow2, UNI2, Titanï¼‰æå–å›¾åƒå—ï¼ˆpatchï¼‰çš„ç‰¹å¾ã€‚æœ€åŽï¼Œä½¿ç”¨å¤šç¤ºä¾‹å­¦ä¹ èšåˆå™¨ï¼ˆAB-MILå’ŒTransMILï¼‰å°†å›¾åƒå—çš„ç‰¹å¾èšåˆä¸ºæ•´å¼ åˆ‡ç‰‡çš„ç‰¹å¾ï¼Œå¹¶è¿›è¡Œæ·‹å·´ç˜¤äºšåž‹åˆ†ç±»ã€‚

**å…³é”®åˆ›æ–°**ï¼šè®ºæ–‡çš„ä¸»è¦åˆ›æ–°åœ¨äºŽæž„å»ºäº†é¦–ä¸ªå¤šä¸­å¿ƒæ·‹å·´ç˜¤äºšåž‹åŸºå‡†æ•°æ®é›†ï¼Œå¹¶ç³»ç»Ÿåœ°è¯„ä¼°äº†å¤šç§çŽ°æœ‰æ¨¡åž‹åœ¨è¯¥æ•°æ®é›†ä¸Šçš„æ€§èƒ½ã€‚è¿™ä¸ºåŽç»­ç ”ç©¶æä¾›äº†ä¸€ä¸ªç»Ÿä¸€çš„è¯„ä¼°å¹³å°ï¼Œå¹¶æ­ç¤ºäº†çŽ°æœ‰æ¨¡åž‹åœ¨æ³›åŒ–èƒ½åŠ›æ–¹é¢çš„ä¸è¶³ã€‚æ­¤å¤–ï¼Œè®ºæ–‡è¿˜ç ”ç©¶äº†ä¸åŒæ”¾å¤§å€æ•°å¯¹æ¨¡åž‹æ€§èƒ½çš„å½±å“ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡çš„å…³é”®è®¾è®¡åŒ…æ‹¬ï¼š1) æ•°æ®é›†çš„å¤šä¸­å¿ƒç‰¹æ€§ï¼Œä¿è¯äº†æ•°æ®çš„å¤šæ ·æ€§å’Œä»£è¡¨æ€§ï¼›2) é€‰æ‹©äº†å¤šç§å…·æœ‰ä»£è¡¨æ€§çš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹å’Œå¤šç¤ºä¾‹å­¦ä¹ èšåˆå™¨ï¼Œä¿è¯äº†è¯„ä¼°çš„å…¨é¢æ€§ï¼›3) è¿›è¡Œäº†ä¸åŒæ”¾å¤§å€æ•°çš„å®žéªŒï¼ŒæŽ¢ç´¢äº†æœ€ä½³çš„å›¾åƒåˆ†è¾¨çŽ‡ï¼›4) ä½¿ç”¨å¹³è¡¡å‡†ç¡®çŽ‡ä½œä¸ºè¯„ä¼°æŒ‡æ ‡ï¼Œé¿å…äº†ç±»åˆ«ä¸å¹³è¡¡å¸¦æ¥çš„å½±å“ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

å®žéªŒç»“æžœè¡¨æ˜Žï¼Œåœ¨åŒåˆ†å¸ƒæµ‹è¯•é›†ä¸Šï¼Œæ¨¡åž‹èƒ½å¤Ÿè¾¾åˆ°è¶…è¿‡80%çš„å¤šç±»å¹³è¡¡å‡†ç¡®çŽ‡ã€‚ç„¶è€Œï¼Œåœ¨å¼‚åˆ†å¸ƒæµ‹è¯•é›†ä¸Šï¼Œæ€§èƒ½æ˜¾è‘—ä¸‹é™è‡³60%å·¦å³ï¼Œè¡¨æ˜Žæ¨¡åž‹åœ¨å¤šä¸­å¿ƒæ•°æ®ä¸Šçš„æ³›åŒ–èƒ½åŠ›ä»ç„¶ä¸è¶³ã€‚æ”¾å¤§å€æ•°ç ”ç©¶è¡¨æ˜Žï¼Œ40xåˆ†è¾¨çŽ‡å·²è¶³å¤Ÿï¼Œæ›´é«˜çš„åˆ†è¾¨çŽ‡æ²¡æœ‰å¸¦æ¥æ€§èƒ½æå‡ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæžœå¯åº”ç”¨äºŽè¾…åŠ©ç—…ç†è¯Šæ–­ï¼Œæé«˜æ·‹å·´ç˜¤äºšåž‹è¯Šæ–­çš„æ•ˆçŽ‡å’Œå‡†ç¡®æ€§ã€‚é€šè¿‡æ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œå¯ä»¥å‡å°‘å¯¹æ˜‚è´µè®¾å¤‡å’Œä¸“ä¸šäººå‘˜çš„ä¾èµ–ï¼Œé™ä½Žè¯Šæ–­æˆæœ¬ï¼Œå¹¶ç¼©çŸ­è¯Šæ–­æ—¶é—´ã€‚æœªæ¥ï¼Œè¯¥æŠ€æœ¯æœ‰æœ›æŽ¨å¹¿åˆ°å…¶ä»–ç—…ç†è¯Šæ–­é¢†åŸŸï¼Œå®žçŽ°æ›´æ™ºèƒ½åŒ–çš„åŒ»ç–—æœåŠ¡ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Timely and accurate lymphoma diagnosis is essential for guiding cancer treatment. Standard diagnostic practice combines hematoxylin and eosin (HE)-stained whole slide images with immunohistochemistry, flow cytometry, and molecular genetic tests to determine lymphoma subtypes, a process requiring costly equipment, skilled personnel, and causing treatment delays. Deep learning methods could assist pathologists by extracting diagnostic information from routinely available HE-stained slides, yet comprehensive benchmarks for lymphoma subtyping on multicenter data are lacking. In this work, we present the first multicenter lymphoma benchmarking dataset covering four common lymphoma subtypes and healthy control tissue. We systematically evaluate five publicly available pathology foundation models (H-optimus-1, H0-mini, Virchow2, UNI2, Titan) combined with attention-based (AB-MIL) and transformer-based (TransMIL) multiple instance learning aggregators across three magnifications (10x, 20x, 40x). On in-distribution test sets, models achieve multiclass balanced accuracies exceeding 80% across all magnifications, with all foundation models performing similarly and both aggregation methods showing comparable results. The magnification study reveals that 40x resolution is sufficient, with no performance gains from higher resolutions or cross-magnification aggregation. However, on out-of-distribution test sets, performance drops substantially to around 60%, highlighting significant generalization challenges. To advance the field, larger multicenter studies covering additional rare lymphoma subtypes are needed. We provide an automated benchmarking pipeline to facilitate such future research.

